NCT01057225View on ClinicalTrials.gov

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

March 31, 2014

Study Completion Date

September 5, 2017

Conditions
Multiple MyelomaStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Interventions
DRUG

carfilzomib

Given IV

DRUG

cyclophosphamide

Given orally

DRUG

thalidomide

Given orally

DRUG

dexamethasone

Given orally

Trial Locations (3)

55905

Mayo Clinic, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

29425-6350

Medical University of South Carolina, Charleston

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER